Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | Mar 31, 2026 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|
| Revenue | 2.68bn | 4.10bn | 3.10bn | 2.27bn | 3.73bn | 2.75bn |
| Cost of revenue | 581m | 549m | 544m | 506m | 465m | 506m |
| Research and development | 638m | 587m | 610m | 568m | 524m | 519m |
| Selling, general and administrative | 296m | 330m | 307m | 294m | 335m | 315m |
| Operating expenses | 2.59bn | 2.47bn | 2.48bn | 2.23bn | 2.21bn | 2.25bn |
| Operating income | 86m | 1.63bn | 612m | 38m | 1.53bn | 497m |
| Pre-tax income | 281m | 1.79bn | 779m | 173m | 1.74bn | 681m |
| Income tax | 121m | 418m | 137m | 19m | 367m | 126m |
| Net income | 160m | 1.37bn | 642m | 154m | 1.37bn | 555m |
| Earnings per share | 0.27 | 2.25 | 1.04 | 0.25 | 2.17 | 0.87 |
| Earnings per share, diluted | 0.26 | 2.21 | 1.03 | 0.24 | 2.13 | 0.86 |
| Weighted average shares | 598m | 611m | 615m | 621m | 631m | 635m |
| Weighted average shares, diluted | 608m | 621m | 626m | 632m | 642m | 649m |
| Metric | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 7.04bn | 6.56bn | 7.53bn | 7.40bn | 7.60bn | 6.86bn | 14.20bn | 18.19bn |
| Short-term investments | 4.97bn | 4.45bn | 4.16bn | 3.95bn | 3.89bn | 3.75bn | 3.58bn | 3.37bn |
| Current assets | 23.60bn | 18.80bn | 19.54bn | 23.18bn | 21.30bn | 17.18bn | 18.32bn | 22.25bn |
| Total assets | 26.83bn | 22.21bn | 23.06bn | 26.99bn | 25.06bn | 20.96bn | 22.17bn | 26.32bn |
| Current liabilities | 16.36bn | 13.65bn | 14.04bn | 18.82bn | 16.73bn | 10.16bn | 11.34bn | 15.83bn |
| Short-term debt | 0 | 2.00bn | 2.00bn | 2.00bn | 2.00bn | 0 | — | — |
| Long-term debt | 2.48bn | 0 | 0 | 0 | 0 | 2.00bn | 1.99bn | 1.99bn |
| Total liabilities | 19.19bn | 14.01bn | 14.45bn | 19.21bn | 17.12bn | 12.55bn | 13.68bn | 18.32bn |
| Equity | 7.64bn | 8.20bn | 8.61bn | 7.78bn | 7.94bn | 8.41bn | 8.49bn | 8.00bn |
| Metric | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
| Operating cash flow | 1.71bn | 1.79bn |
| Share-based compensation | 410m | 358m |
| Investing cash flow | −461m | −151m |
| Share buybacks | 1.09bn | 807m |
| Financing cash flow | 2.97bn | 2.15bn |
Amounts in USD unless stated otherwise. Sources: Nasdaq Trader, Yahoo Finance, U.S. Securities and Exchange Commission (EDGAR)